Today: 4 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

UK mortgage rates have dropped to their lowest since September 2022, with typical two-year fixes at 4.86% and five-year deals at 4.91%, according to Moneyfacts. Major lenders have cut prices, sparking talk of a mortgage price war. Meanwhile, China’s trade surplus topped $1 trillion for the first time after exports rose nearly 6% year-on-year in November.
8 December 2025
·
NIO Stock on December 8, 2025: Deliveries Surge, Shares Slide and Analysts Split on the Outlook

NIO Stock on December 8, 2025: Deliveries Surge, Shares Slide and Analysts Split on the Outlook

NIO shares traded near $5.12 in New York on December 8, 2025, down 29% over the past month despite record third-quarter deliveries of 87,071 vehicles and revenue of RMB 21.79 billion. Gross margin rose to 13.9%, but the company posted a net loss of RMB 3.48 billion, narrowing losses year over year. The stock’s price-to-sales ratio stands at 1.2x, close to the U.S. auto industry median.
8 December 2025
··
Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals reported Phase 1b/2 trial data showing its AI-discovered drug REC-4881 reduced polyp burden by a median 43% at 13 weeks in patients with familial adenomatous polyposis. Shares rose as much as 6% pre-market before settling in the mid-$4 range. Most patients maintained or improved reductions after stopping treatment. No approved drugs currently exist for this condition.
8 December 2025
···
Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia shares traded near $183 on December 8, 2025, following a major CUDA 13.1 software release, a $2 billion Synopsys deal, and Q3 FY26 revenue of $57 billion. The company’s market cap stands around $4.4 trillion. New U.S. export controls and China bans have heightened geopolitical risks. Wall Street’s 12-month price targets average $250–$260, with most analysts rating NVDA a “Strong Buy.”
8 December 2025
····
BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai shares traded around $6.4–$6.5 on December 8, giving the company a market cap near $3 billion. The stock is up 49% year-to-date, but revenue is falling and losses continue. The company doubled its authorized share count and short interest stands near 20%. BigBear.ai opened a new office in Abu Dhabi, expanding into the Middle East.
8 December 2025
··
Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power postponed its special shareholder meeting to January 29, 2026, with a new record date of December 12. Shares traded near $2.13 midday, valuing the company at about $3 billion. The firm announced its first liquid hydrogen supply contract with NASA, worth up to $2.8 million. Short interest remains high at around 30% of the float.
8 December 2025
··
Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings said December 8 it will invest up to $11 million in Ukraine’s Drone Fight Group, aiming to bring DFG’s combat-tested drones to U.S. and allied markets. The announcement follows a year in which Ondas’ market cap soared to $3.4 billion, with shares trading near $9.30, up over 6,500% from a year ago. Ondas plans to manufacture the drones in the U.S. and showcase them to U.S. defense and tech leaders.
8 December 2025
··
HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

Gildan Activewear closed its acquisition of HanesBrands on December 1, 2025, ending HBI’s status as an independent stock and triggering its delisting from the NYSE. Each HanesBrands share was exchanged for 0.102 Gildan shares plus $0.80 in cash. The deal valued HanesBrands at about $4.4 billion including debt. As of December 8, the implied value per former HBI share is approximately $6.84.
8 December 2025
···
Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Paramount Skydance launched a $30-per-share hostile all-cash bid for Warner Bros. Discovery on December 8, sending WBD stock up as much as 7% to near $28. The offer, valued at about $74.4 billion in equity, bypasses the board and challenges Netflix’s earlier $82.7 billion deal. Over 43 million WBD shares traded, several times normal volume. The tender offer expires in early January 2026 unless extended.
8 December 2025
··
Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics Stock Soars on Duchenne Trial Data: What December 8 Means for DYN Investors

Dyne Therapeutics shares jumped 14% to $23.20 by mid-afternoon Monday after the company reported its Phase 1/2 DELIVER trial in Duchenne muscular dystrophy met its primary endpoint. The stock touched an intraday high near $25.68 on volume over 2.5 million shares. Dyne plans to seek U.S. accelerated approval in 2026. The company reported $792 million in cash as of Q3 2025.
8 December 2025
·
IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM to Acquire Confluent for $11 Billion in All‑Cash Deal to Power Enterprise AI Data Streaming

IBM will acquire Confluent in an all-cash deal valued at $11 billion, paying $31 per share. Both boards approved the transaction, with Confluent shareholders holding 62% of voting power backing the deal. Shares of Confluent jumped up to 30% in pre-market trading, while IBM stock slipped about 2%. The companies expect to close the deal by mid-2026, pending regulatory and shareholder approval.
8 December 2025
····
Bank of Canada Expected to Hold Interest Rate at 2.25% on December 10 as Fed Prepares to Cut

Bank of Canada Expected to Hold Interest Rate at 2.25% on December 10 as Fed Prepares to Cut

The Bank of Canada is expected to hold its key interest rate at 2.25% on December 10, according to a Reuters poll of 33 economists. The U.S. Federal Reserve is widely forecast to cut its rate by 25 basis points the same day. The Bank of Canada will announce its decision at 9:45 a.m. ET, followed by a press conference at 10:30 a.m. The Canadian rate has fallen from 3.25% at the start of 2025.
8 December 2025
·
CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH plc Stock: S&P 500 Debut, Buybacks and 2026 Infrastructure Tailwinds — Latest News & Forecasts (8 December 2025)

CRH will join the S&P 500 on December 22, the company confirmed Monday. Its New York-listed shares surged in pre-market trading, jumping from $119.65 to about $128 after the announcement. London shares also hit a new 12-month high, reaching 9,602p. S&P Dow Jones Indices said CRH will replace LKQ in the quarterly rebalance.
8 December 2025
···
IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM Stock After the $11 Billion Confluent Deal: Price, Forecasts and AI Strategy in December 2025

IBM said December 8 it will acquire Confluent Inc. for $11 billion in cash, or $31 per share. IBM shares traded flat to slightly lower near $308 following the announcement, while Confluent jumped over 20%. The deal is expected to close by mid-2026. IBM’s market cap stands near $290 billion, with shares up more than 40% year-to-date.
8 December 2025
····
GameStop (GME) Stock Today: Price, Q3 2025 Earnings Preview, Short Interest and Forecasts

GameStop (GME) Stock Today: Price, Q3 2025 Earnings Preview, Short Interest and Forecasts

GameStop shares traded near $23 midday December 8, with a market cap of $10.3 billion, ahead of its Q3 2025 earnings report on December 9. Analysts expect Q3 revenue of about $987 million and adjusted EPS of $0.20, both up from last year. Short interest remains high at 16.9% of float, with 69 million shares sold short. GameStop holds over $500 million in Bitcoin and reported a cash balance of $8.7 billion in Q2.
8 December 2025
··
Strive Asset Management Stock (ASST): Bitcoin Treasury High‑Flyer Under Pressure – Latest News, Analysis and 2026 Outlook

Strive Asset Management Stock (ASST): Bitcoin Treasury High‑Flyer Under Pressure – Latest News, Analysis and 2026 Outlook

Strive, Inc. (Nasdaq: ASST) traded at about $0.90 per share in early December 2025, down 8% on the day and over 40% for the month. The company holds more than 7,500 Bitcoin and is pursuing an all-stock merger with Semler Scientific. Strive’s market cap stands near $740 million, with volatility underscored by a beta of 17.4. The firm faces a public dispute with MSCI over Bitcoin-focused companies’ index inclusion.
8 December 2025
···
Energy Transfer LP (ET) Stock on December 8, 2025: Q3 Earnings, 8% Yield and LNG Delay Shape the Outlook

Energy Transfer LP (ET) Stock on December 8, 2025: Q3 Earnings, 8% Yield and LNG Delay Shape the Outlook

Energy Transfer LP traded near $16.80 per unit midday Dec. 8, 2025, valuing the partnership at $57.6 billion, down over 20% from its January high. Q3 adjusted EPS missed estimates at $0.28, with revenue at $19.95 billion, both below forecasts. Despite the earnings miss, the company reported record NGL and refined products terminal volumes. Management maintains 2025 adjusted EBITDA guidance of $16.1–$16.5 billion.
8 December 2025
·
Lumentum (LITE) Stock Hits Fresh Highs on AI Data Center Boom – Earnings, Forecasts and Risks as of December 8, 2025

Lumentum (LITE) Stock Hits Fresh Highs on AI Data Center Boom – Earnings, Forecasts and Risks as of December 8, 2025

Lumentum Holdings shares closed at $331.41 on December 5, 2025, and traded near $344 pre-market December 8, marking a 219% gain over the past year and a new all-time high. The company’s Cloud & Networking segment drove growth, posting $424 million in Q4 FY25 revenue, up 66.5% year over year and accounting for 88% of total sales.
8 December 2025
····
Paramount Skydance (PSKY) Stock Today: Netflix–Warner Bros. Deal Triggers a 16% Slide – What Comes Next for the New Hollywood Giant?

Paramount Skydance (PSKY) Stock Today: Netflix–Warner Bros. Deal Triggers a 16% Slide – What Comes Next for the New Hollywood Giant?

Paramount Skydance shares fell nearly 16.5% last week, closing at $13.37 on December 5 after losing the Warner Bros. Discovery bid to Netflix. The stock was the S&P 500’s biggest percentage loser for the week. Pre-market trading Monday showed only a slight rebound. Analysts now forecast low revenue growth and limited upside, with most ratings at Sell or Reduce.
8 December 2025
··
1 … 507 508 509 510 511 … 587

Stock Market Today

  • UNH and CVS Lead S&P 500 Health Insurers with Buy Signals
    June 4, 2026, 10:22 AM EDT. UnitedHealth Group (UNH) and CVS Health are among the top gainers in the S&P 500 early Thursday, driven by improving health care utilization trends. Bank of America (BofA) upgraded UnitedHealth Group, contributing to the positive momentum. This upgrade signals increasing confidence in the health insurance sector amid evolving market conditions.

Latest articles

UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure

UnitedHealth Shares Climb as Wall Street Sees Less Cost Pressure

4 June 2026
UnitedHealth Group surged 5.7% after Bank of America upgraded the stock to Buy and Morgan Stanley hiked its price target, as Wall Street cited signs of easing medical costs and a favorable second-quarter earnings setup, with shares trading near $398 and the board boosting the quarterly dividend to $2.32, even as a Massachusetts lawsuit poses ongoing risk.
Ciena Corporation Stock Faces $416 Reality Check as AI Network Push Heads to Brazil

Ciena shares fall after strong results, AI trade takes a hit

4 June 2026
Ciena shares plunged 9.5% premarket to $561.51 despite beating Q2 revenue and profit estimates and raising full-year guidance, as investors—already pricing in an AI-driven boom—found the outlook insufficient; two customers made up 34% of revenue, highlighting risk from concentrated orders and volatile AI-linked demand.
Splash Beverage Stock Climbs — NYSE Details for Traders

Splash Beverage Stock Climbs — NYSE Details for Traders

4 June 2026
Splash Beverage soared 71% to $0.2420 after filing a plan to regain NYSE American compliance, with shares quoted at $0.3650 premarket as investors react to survival efforts amid expired Medterra CBD talks, a sharp revenue drop to $4,224, a $2.14 million loss, and just $381,195 in cash, leaving the company dependent on new deals and financing to avoid delisting.
Intel Shares Drop Even as Tech Climbs—AI Trade Not Enough

Intel Shares Dip Premarket Despite Foxconn AI Deal

4 June 2026
Intel shares slid 3.71% to $108.53 premarket as a new AI partnership with Foxconn failed to offset a chip-sector selloff sparked by Broadcom’s disappointing results; investors face uncertainty as Intel and Foxconn gave no financial details, customer names, or launch timeline for their AI collaboration, raising questions about how soon the deal could boost revenue.
Archer Aviation stock moves up as investors watch for 2026 air-taxi test

Archer Aviation Drops Pre-Market With Cash Burn In Focus

4 June 2026
Archer Aviation shares slid 3.3% pre-market to $6.53 as investors weighed heavy quarterly losses and rising cash needs for certification, testing, and manufacturing, despite progress on FAA milestones; the company warned it may need more capital on poor terms if costs rise or development delays, leaving the stock exposed to regulatory and financial risks.
Go toTop